Researcher.Life Logo

Cancer Medicine : Impact Factor & More

eISSN: 2045-7634pISSN: 2045-7634
JournalOpen Access

Key Metrics

CiteScore
6.7
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
Scite Index
0.87 5-Year SI
SJR
Q3Oncology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Medicine

Cancer Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesEUR 2300 | GBP 1950 | USD 3025
Publication Time19
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 19
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Cancer Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Medicine

A Novel Strategy to Produce CAR\u2010\u03b3\u03b4 T Cells via Site\u2010Directed Gene Integration by a Combination of CRISPR/Cas9 and AAV
  • 18 May 2026
  • Cancer Medicine
Integrated Molecular Risk Stratification and Measurable Residual Disease\u2010Guided Consolidation Improve Outcomes in Pediatric Non\u2010Down Syndrome Acute Megakaryoblastic Leukemia
  • 17 May 2026
  • Cancer Medicine
Type 2 Diabetes, Glycemic Traits and Overall Cancer Risk: A Large\u2010Scale Prospective Cohort Study
  • 17 May 2026
  • Cancer Medicine
Germline Pathogenic Variants in HER2\u2010Positive Breast Cancer: Spectrum and Clinical Implications in a High\u2010Risk Chinese Cohort
  • 15 May 2026
  • Cancer Medicine
Sequential Use of Systemic Therapy With Locoregional Therapy for Hepatocellular Carcinoma in Japan: Analyses of Real\u2010World Data Based on a Health Claims Database
  • 15 May 2026
  • Cancer Medicine
EXPRESSION OF CONCERN: Overexpression of TNKS1BP1 in Lung Cancers and Its Involvement in Homologous Recombination Pathway of DNA Double\u2010Strand Breaks
  • 15 May 2026
  • Cancer Medicine
A Novel Strategy to Produce CAR\u2010\u03b3\u03b4 T Cells via Site\u2010Directed Gene Integration by a Combination of CRISPR/Cas9 and AAV
  • 18 May 2026
  • Cancer Medicine
Integrated Molecular Risk Stratification and Measurable Residual Disease\u2010Guided Consolidation Improve Outcomes in Pediatric Non\u2010Down Syndrome Acute Megakaryoblastic Leukemia
  • 17 May 2026
  • Cancer Medicine
Type 2 Diabetes, Glycemic Traits and Overall Cancer Risk: A Large\u2010Scale Prospective Cohort Study
  • 17 May 2026
  • Cancer Medicine
Germline Pathogenic Variants in HER2\u2010Positive Breast Cancer: Spectrum and Clinical Implications in a High\u2010Risk Chinese Cohort
  • 15 May 2026
  • Cancer Medicine
Sequential Use of Systemic Therapy With Locoregional Therapy for Hepatocellular Carcinoma in Japan: Analyses of Real\u2010World Data Based on a Health Claims Database
  • 15 May 2026
  • Cancer Medicine
EXPRESSION OF CONCERN: Overexpression of TNKS1BP1 in Lung Cancers and Its Involvement in Homologous Recombination Pathway of DNA Double\u2010Strand Breaks
  • 15 May 2026
  • Cancer Medicine

FAQs on Cancer Medicine